IP Library Granted Patent US 12,161,713
Granted Patent B2
US 12,161,713 · App. 17/414,187 · Granted Dec 10, 2024

Prime-boost vaccination regimen

Inventors: Erin Linn Strait (Spring Hill, KS); Mark A. Mogler (Ames, IA); Pravina Kitikoon (Overland Park, KS); Ruud Philip Antoon Maria Segers (Boxmeer, NL); Erwin van den Born (Wageningen, NL)
Assignee: Intervet Inc.
A61K39/215A61K39/12A61P31/14C12N7/00A61K2039/5254A61K2039/5258A61K2039/545A61K2039/552C12N2770/10023C12N2770/10034C12N2770/10071C12N2770/20034C12N2770/20071
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,161,713
App. No.
17/414,187
Granted
Dec 10, 2024
Kind
B2
Abstract

The present invention relates to a method of vaccination. Specifically the invention regards to a prime-boost vaccination regimen for protecting a target animal against infection or disease caused by a virus, wherein the vaccination regimen comprises the administration to said target animal of a vaccine comprising a live attenuated form of said virus, followed by the administration to said target animal of a vaccine comprising an RP encoding one or more antigens from said virus.

Claims (8)

1. A method of vaccination for protecting a target animal against infection or disease caused by a virus, wherein the method comprises

administering a vaccine comprising a live attenuated form of said virus to the target animal, followed by

administering a vaccine comprising a replicon particle (RP) encoding one or more antigens from said virus to the target animal.

2. The method of claim 1 , wherein the target animal is a porcine.

3. The method of claim 2 , wherein said virus is selected from the group consisting of a porcine epidemic diarrhoea virus (PEDV) and a porcine reproductive and respiratory syndrome virus (PRRSV).

4. The method of claim 1 , wherein the vaccine comprising the RP comprises at least one further RP encoding one or more antigens from said virus.

5. The method of claim 1 , wherein at least one viral antigen encoded by the RP is from a virus that is a variant within the species of the live attenuated virus.

6. The method of claim 1 , wherein one or both of the vaccines comprise an adjuvant.

Assignments (2)
CHANGE OF ADDRESS Recorded Sep 26, 2023
From: INTERVET INC.
To: INTERVET INC.
Reel/Frame 065028/0818 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2021
From: STRAIT, ERIN; MOGLER, MARK A.; KITIKOON, PRAVINA; SEGERS, RUUD PHILIP ANTOON; VAN DEN BORN, ERWIN
To: INTERVET INC.
Reel/Frame 056551/0340 →
Continuity (2)
Provisional Application 62782508 · Dec 20, 2018
Related Publication 20220023414A1 · Jan 27, 2022